Eglen RM - Search Results

1

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.

Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, Loury D, Eglen RM. Hegde SS, et al. Among authors: eglen rm. Br J Pharmacol. 1997 Apr;120(8):1409-18. doi: 10.1038/sj.bjp.0701048. Br J Pharmacol. 1997. PMID: 9113359 Free PMC article.

2

RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist.

Hegde SS, Bonhaus DW, Johnson LG, Leung E, Clark RD, Eglen RM. Hegde SS, et al. Among authors: eglen rm. Br J Pharmacol. 1995 Jul;115(6):1087-95. doi: 10.1111/j.1476-5381.1995.tb15922.x. Br J Pharmacol. 1995. PMID: 7582507 Free PMC article.

3

Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain.

To ZP, Bonhaus DW, Eglen RM, Jakeman LB. To ZP, et al. Among authors: eglen rm. Br J Pharmacol. 1995 May;115(1):107-16. doi: 10.1111/j.1476-5381.1995.tb16327.x. Br J Pharmacol. 1995. PMID: 7647964 Free PMC article.

4

5-HT4 receptor mediated stimulation of gastric emptying in rats.

Hegde SS, Wong AG, Perry MR, Ku P, Moy TM, Loeb M, Eglen RM. Hegde SS, et al. Among authors: eglen rm. Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):589-95. doi: 10.1007/BF00170157. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7675116

5

The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.

Wong EH, Clark R, Leung E, Loury D, Bonhaus DW, Jakeman L, Parnes H, Whiting RL, Eglen RM. Wong EH, et al. Among authors: eglen rm. Br J Pharmacol. 1995 Feb;114(4):851-9. doi: 10.1111/j.1476-5381.1995.tb13282.x. Br J Pharmacol. 1995. PMID: 7773546 Free PMC article.

6

Cardiovascular effects of R-alpha-methylhistamine, a selective histamine H3 receptor agonist, in rats: lack of involvement of histamine H3 receptors.

Hegde SS, Chan P, Eglen RM. Hegde SS, et al. Among authors: eglen rm. Eur J Pharmacol. 1994 Jan 4;251(1):43-51. doi: 10.1016/0014-2999(94)90441-3. Eur J Pharmacol. 1994. PMID: 7907986

7

RS 23597-190: a potent and selective 5-HT4 receptor antagonist.

Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Wong EH. Eglen RM, et al. Br J Pharmacol. 1993 Sep;110(1):119-26. doi: 10.1111/j.1476-5381.1993.tb13780.x. Br J Pharmacol. 1993. PMID: 8220871 Free PMC article.

8

Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.

Hegde SS, Bonhaus DW, Stanley W, Eglen RM, Moy TM, Loeb M, Shetty SG, DeSouza A, Krstenansky J. Hegde SS, et al. Among authors: eglen rm. J Pharmacol Exp Ther. 1995 Dec;275(3):1261-6. J Pharmacol Exp Ther. 1995. PMID: 8531090

9

Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo.

Eglen RM, Bonhaus DW, Johnson LG, Leung E, Clark RD. Eglen RM, et al. Br J Pharmacol. 1995 Aug;115(8):1387-92. doi: 10.1111/j.1476-5381.1995.tb16628.x. Br J Pharmacol. 1995. PMID: 8564196 Free PMC article.

10

Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.

Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, Hegde SS. Stanley WC, et al. Among authors: eglen rm. Br J Pharmacol. 1997 Aug;121(8):1803-9. doi: 10.1038/sj.bjp.0701315. Br J Pharmacol. 1997. PMID: 9283721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page